Liquidia (LQDA) Other Non-Current Liabilities (2020 - 2026)
Liquidia (LQDA) posted quarterly Other Non-Current Liabilities of $8.5 million for Q1 2026, up 13.43% year-over-year from $7.5 million in Q1 2025, and up 1.94% quarter-over-quarter from $8.4 million in Q4 2025.
Liquidia (LQDA) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Liquidia's Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $8.5 million for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 13.43% year-over-year to $8.5 million; the TTM figure through Mar 2026 stood at $8.5 million (up 13.43% YoY), while the FY2025 annual figure was $8.4 million, up 14.85% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $8.5 million, up from $8.4 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $8.5 million in Q1 2026, with the low at $6.4 million in Q1 2022.
- The 5-year median for Other Non-Current Liabilities is $6.7 million (2024), against an average of $7.2 million.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities soared 208.42% in 2022, then increased 1.5% in 2024.
- Liquidia's Other Non-Current Liabilities stood at $6.6 million in 2022, then increased by 1.71% to $6.7 million in 2023, then increased by 8.84% to $7.3 million in 2024, then climbed by 14.85% to $8.4 million in 2025, then climbed by 1.94% to $8.5 million in 2026.
- Business Quant data shows LQDA's Other Non-Current Liabilities at $8.5 million in Q1 2026, $8.4 million in Q4 2025, and $8.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Liquidia | 6.34 Bn | 6.05 Bn | 160.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.55 Mn |
| Mar 31, 2026 | 8.55 Mn |
| Dec 31, 2025 | 8.38 Mn |
| Sep 30, 2025 | 8.28 Mn |
| Jun 30, 2025 | 7.97 Mn |
| Mar 31, 2025 | 7.54 Mn |
| Dec 31, 2024 | 7.30 Mn |
| Sep 30, 2024 | 7.20 Mn |
| Jun 30, 2024 | 6.93 Mn |
| Mar 31, 2024 | 6.71 Mn |
| Dec 31, 2023 | 6.71 Mn |
| Sep 30, 2023 | 6.70 Mn |
| Jun 30, 2023 | 6.70 Mn |
| Mar 31, 2023 | 6.61 Mn |
| Dec 31, 2022 | 6.59 Mn |
| Sep 30, 2022 | 6.56 Mn |
| Jun 30, 2022 | 6.51 Mn |
| Mar 31, 2022 | 6.42 Mn |
| Dec 31, 2021 | 6.14 Mn |
| Sep 30, 2021 | 5.07 Mn |